New ‘Agfa HealthCare Saudi Arabia Company Ltd’ Eyes Local Key Growth Market
News May 21, 2013
Agfa HealthCare recently announced the establishment of a new branch in the Kingdom of Saudi Arabia, called Agfa HealthCare Saudi Arabia Company Ltd. The new company was launched during a press conference held at the Ritz Carlton Hotel in Riyadh, Kingdom of Saudi Arabia.
Agfa HealthCare has been active for some time in the Kingdom of Saudi Arabia, the largest country in the region. By setting up a legal entity within the country, the company is set to enhance its support to customers, and provide better solutions and technology.
Agfa Healthcare further revealed its new partnership with Advanced Electronic Company and Gulf Medical Company in the Kingdom, thus capitalizing on the wide local experience and market knowledge in the medical and IT sectors to boost their presence and market share.
“Agfa HealthCare is committed to expanding its presence and visibility throughout this very important region,” commented Zyad Neil Benaissa, Managing Director Agfa HealthCare Solutions LLC, Middle East. “The decision to open a new subsidiary in the country comes in line with our strategy for growth and development.”
“Our goal is to maintain and improve customer satisfaction amongst our customers in the Kingdom of Saudi Arabia by providing strong support processes and working side by side with our customers to introduce and implement the latest state-of-the-art products and services,” explains Mustafa Hamdy, General Manager, Agfa HealthCare Saudi Arabia Company Ltd.
“Having a permanent and continuous presence in this major market is an important step in achieving our plans.”
Enterome and Nestlé Health Sciences Launch New Diagnostics CompanyNews
Enterome and Nestlé Health Sciences join to create Microbiome Diagnostics Partners, a company that will enable the development and diagnostics for multiple diseases including inflammatory bowel diseases (IBD) and liver diseases.READ MORE
Material From Shellfish Boosts Sensitivity of Diagnostic TestsNews
By adding polydopamine at a key step, the sensitivity of diagnostic tests and bioassays can be increased by as many as 100 to 1,000 times.READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Introduction to Next Generation Sequencing
Apr 09 - Apr 12, 2018
EMBL Course: RNA Sequencing Library Preparation - How Low Can You Go?
Mar 19 - Mar 23, 2018
EMBL Course: Analysis and Integration of Transcriptome and Proteome Data
Mar 12 - Mar 16, 2018